Hindi, asked by seemasinghvi1010, 19 days ago

Advertising making on corona vaccine center in hindi

Attachments:

Answers

Answered by hjeet176kaur
0

Answer:

Guidance on COVID-19 Vaccination at Work Places (Government & Private)

1. Background:

a. As per the recommendation of National Expert Group on Vaccine Administration for

COVID-19 (NEGVAC), the prioritized group of beneficiaries for COVID-19 vaccination has

been expanded to cover general population aged 45 years and above from 1st April 2021.

b. A substantial proportion of population aged between 45-59 years (in some cases up to 65

years) are in the organized sector of the economy. They are involved in formal occupation

in offices (government and private), in manufacturing and services etc.

c. COVID-19 vaccination sessions may be organized at Work Places which are having about

100 eligible and willing beneficiaries (to facilitate optimal utilization of vaccine dosage and

reduce wastage) for COVID-19 vaccination. Organizing vaccination at Work Place will not

only be convenient to the staff at Work Places but also help to avoid travel and hence

reducing the risk of exposure to COVID-19 virus.

2. Identification of Work Places for COVID-19 vaccination:

a. The District Task Force (DTF) chaired by District Magistrate and Urban Task Force (UTF)

chaired by Municipal Commissioner will identify such government and private Work

Places after due deliberations with relevant employers and / or Head of offices.

b. Work Place management will designate one of theirsenior staff to work as “Nodal Officer”

to coordinate with district health authorities/ private COVID Vaccination Centres (CVCs)

and support vaccination activities.

c. The Nodal Officer will oversee and facilitate all aspects of vaccination at Work Place CVC

like registration of beneficiaries, availability of physical and IT infrastructure and oversight

to vaccination etc.

3. Identification of Eligible and Willing Beneficiaries at Work Places

a. Only employees of Work Place aged 45 years or more will be eligible for vaccination at

Work Place, no outsiders including eligible family members will be allowed for vaccination

at “CVC at Work Place”.

b. Beneficiaries must be registered in Co-WIN portal prior to vaccination. CVC Nodal Officer

will ensure registration of all targeted beneficiaries and facility of on-the spot registration

will also be available but only to employees of the work place.

4. Registration of Work Place as CVC in Co-WIN

a. Once identified, all such Work Place vaccination centres will be registered in the CoWIN

portal as Government or Private COVID-19 Vaccination Centre (CVC) at Work Place.

b. The name of Work Place CVC should be recorded in Co-WIN as full name and not as

abbreviation to have clarity.

c. DTF / UTF will ensure verification of availability of three rooms as waiting, vaccination

and observation rooms at Work Place CVC (refer annexure 1). These rooms should be

part of the permanent structure of the Work Place or proper and stable structure like

hangars should be erected. Temporary shamiyana / tent like structure should not be

used.

d. Once verified, DIO will ensure registration of Work Place CVC in Co-WIN portal

Answered by ribhutripathi18116
0

→  प्रतिक्रिया दें और सुरक्षा करें: लगभग सभी गावी-योग्य देशों में अब COVID-19 की रिपोर्ट के साथ, वैक्सीन एलायंस स्वास्थ्य प्रणालियों को तत्काल धन प्रदान कर रहा है, जिससे देशों को स्वास्थ्य देखभाल श्रमिकों की रक्षा करने, महत्वपूर्ण निगरानी और प्रशिक्षण करने और नैदानिक ​​​​परीक्षण खरीदने में सक्षम बनाया जा सकता है।■

→ बनाए रखें, पुनर्स्थापित करें और मजबूत करें: गवी टीकाकरण सेवाओं को अनुकूलित करने और फिर से शुरू करने, सामुदायिक विश्वास का पुनर्निर्माण करने और उन लोगों को पकड़ने में सहायता करेगा जो महामारी से पहले और दौरान दोनों में चूक गए हैं, साथ ही टीकाकरण प्रणालियों को मजबूत करने में निवेश करने के लिए अधिक लचीला और उत्तरदायी होने के लिए निवेश करेंगे। वे समुदायों की सेवा करते हैं।■

वैश्विक न्यायसंगत पहुंच सुनिश्चित करें: Gavi सह-अग्रणी COVAX है, जो COVID-19 के लिए वैश्विक प्रतिक्रिया हासिल करने का वैश्विक प्रयास है, जो प्रभावी और निष्पक्ष है, अपनी अनूठी विशेषज्ञता का उपयोग करके COVID-19 टीकों के विकास, उत्पादन और वितरण में तेजी लाने और तेजी से मदद करने के लिए। ताकि जिस किसी को उनकी जरूरत हो, वह उन्हें प्राप्त कर सके।■

Attachments:
Similar questions